Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.
Science Advances
Tu, Megan M MM; Lee, Francis Y F FYF; Jones, Robert T RT; Kimball, Abigail K AK; Saravia, Elizabeth E; Graziano, Robert F RF; Coleman, Brianne B; Menard, Krista K; Yan, Jun J; Michaud, Erin E; Chang, Han H; Abdel-Hafiz, Hany A HA; Rozhok, Andrii I AI; Duex, Jason E JE; Agarwal, Neeraj N; Chauca-Diaz, Ana A; Johnson, Linda K LK; Ng, Terry L TL; Cambier, John C JC; Clambey, Eric T ET; Costello, James C JC; Korman, Alan J AJ; Theodorescu, Dan D
Healey, Kelley R KR; Zhao, Yanan Y; Perez, Winder B WB; Lockhart, Shawn R SR; Sobel, Jack D JD; Farmakiotis, Dimitrios D; Kontoyiannis, Dimitrios P DP; Sanglard, Dominique D; Taj-Aldeen, Saad J SJ; Alexander, Barbara D BD; Jimenez-Ortigosa, Cristina C; Shor, Erika E; Perlin, David S DS
De Novo Occurrence of a Variant in ARL3 and Apparent Autosomal Dominant Transmission of Retinitis Pigmentosa.
Plos One
Strom, Samuel P SP; Clark, Michael J MJ; Martinez, Ariadna A; Garcia, Sarah S; Abelazeem, Amira A AA; Matynia, Anna A; Parikh, Sachin S; Sullivan, Lori S LS; Bowne, Sara J SJ; Daiger, Stephen P SP; Gorin, Michael B MB